Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Officer sold ~$8.18M of ABBV shares in the open market
Traded Aug 14, 2026 · Filed Aug 18, 2026
- ~$8.18M
- Reported value · 33K sh @ $250.00
- 74K
- Holds after · shares reported
- +4.2%
- stock since the trade · S&P 500 -1.6%, $249.46 → $259.93 on Oct 1
Why it stands out
AbbVie's CHIEF BUS/STRAT OFFICER sold $8.18M of AbbVie shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 14, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 18, 2026
Officer$1M+
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$8,177,500
Shares × reported transaction price
- Timing vs results
14 days after results of Jul 31, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Price at the time
Closed at $249.46 on Aug 14, 2026, 26% above its 52-week low and 5% below its high, after a 4% drop over the previous 30 trading days